Advertisement
UK markets close in 6 hours 9 minutes

  • FTSE 100

    8,108.90
    +30.04 (+0.37%)
     

  • FTSE 250

    19,813.23
    +211.25 (+1.08%)
     

  • AIM

    755.92
    +2.80 (+0.37%)
     

  • GBP/EUR

    1.1652
    -0.0004 (-0.04%)
     

  • GBP/USD

    1.2515
    +0.0004 (+0.03%)
     

  • Bitcoin GBP

    51,495.34
    +335.16 (+0.66%)
     

  • CMC Crypto 200

    1,389.66
    -6.87 (-0.49%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.70
    +0.13 (+0.16%)
     

  • GOLD FUTURES

    2,363.30
    +20.80 (+0.89%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,047.79
    +130.51 (+0.73%)
     

  • CAC 40

    8,040.40
    +23.75 (+0.30%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Company News for Mar 2, 2020

Zacks Equity Research

  • Shares of Altimmune, Inc. ALT jumped 110.2% after the company reported completion of first development milestone toward a single-dose intranasal coronavirus vaccine

  • Shares of Wayfair Inc. W plunged 10.2% after the company reported a fourth-quarter earnings loss of $2.80 per share versus the Zacks Consensus Estimate of a loss of $2.65

  • Shares of Big Lots, Inc. BIG slumped 29.6% after the company reported fiscal fourth-quarter earnings of $2.39 a share, missing the Zacks Consensus Estimate of $2.53

  • Share of Codexis, Inc. CDXS dropped 12.2% after the company reported fourth quarter earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.06


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Big Lots, Inc. (BIG) : Free Stock Analysis Report
 
Codexis, Inc. (CDXS) : Free Stock Analysis Report
 
PharmAthene, Inc (ALT) : Free Stock Analysis Report
 
Wayfair Inc. (W) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research